Fund Update: Cardano Risk Management B.V. initiates new $125.3M position in $AMAT stock

April 21, 2026

In recent news, Cardano Risk Management B.V. has established a fresh $125.3M position in $AMAT as outlined in a newly filed SEC 13F report, highlighting the financial snapshot for the first quarter of 2026. For a comprehensive view of the fund’s entire portfolio, interested individuals can delve into the details on Quiver Quantitative and stay informed about the primary institutional stakeholders invested in $AMAT.

Delving deeper into recent hedge fund activities surrounding $AMAT, an analysis reveals that 1,169 institutional investors have chosen to increase their stake in $AMAT, while 1,165 opted to decrease their positions in the latest quarter. Noteworthy movements in the market include UBS AM drastically reducing their holdings by 70.7% in Q4 2025, translating to approximately $6,637,974,603. Conversely, Capital Research Global Investors took an opposing stance by boosting their shares by a significant 119.8% during the same period, amounting to an estimated $4,581,971,595. Other notable changes include AllianceBernstein L.P. shedding 49.7% of their shares, and Auto-Owners Insurance Co making a substantial 99.6% reduction in their $AMAT stake during Q1 2026.

Meanwhile, insider trading activities revolving around $AMAT have seen notable transactions within the past six months. While insiders have conducted 8 trades, including sales but no purchases during this period, key figures such as Judy Bruner and Teri A. Little have been actively involved in selling shares, with sums amounting to $2,475,679 and $1,889,262 respectively. Additionally, executives such as Brice Hill and Adam Sanders have also conducted significant sales of $AMAT stocks, recording transactions worth millions of dollars.

Congressional members have also not shied away from trading $AMAT stock, with 2 transactions recorded in the last six months – one purchase and one sale each. Notable trades include Senator John Boozman’s sale of up to $15,000 on 02/27 and Senator Markwayne Mullin’s purchase of up to $50,000 on 12/29.

On the analyst front, Wall Street analysts have been quick to issue their reports and ratings on $AMAT stock. With 11 firms issuing buy ratings on the stock, there seems to be a prevailing sentiment of optimism surrounding its potential. Notable firms such as Needham, Morgan Stanley, and Deutsche Bank have all issued positive ratings in recent months, bolstering investor confidence in $AMAT’s future prospects.

Moreover, analysts have also set price targets for $AMAT stock, with 20 analysts offering estimates in the last six months. The median target lands at $422.5, showcasing a positive outlook on the stock’s potential growth. Analysts such as Craig Ellis, Mehdi Hosseini, and Shane Brett have set target prices ranging from $485.0 to $500.0, reaffirming the positive sentiment surrounding $AMAT.

In conclusion, monitoring the market movements and stakeholder activities surrounding $AMAT can offer valuable insights into its performance and potential for growth. By staying abreast of hedge fund actions, insider trading behaviors, congressional involvement, analyst ratings, and price targets, investors can make informed decisions about their investment strategies in relation to $AMAT stock.